JiMED

Pioneering neurotechnology to restore life, connection, and dignity. JiMED is a Japan-based medtech startup developing wireless implantable Brain-Computer Interfaces (wiBCIs) for patients with severe neurological conditions such as ALS and spinal cord injuries. Our mission is to enable communication and mobility for those who are fully locked-in—empowering them to reconnect with the world. Rooted in advanced research from Osaka University, we are building a clinically viable, minimally invasive BCI system that captures high-resolution brain signals with fewer electrodes and lower power consumption. Our proprietary technologies are designed to maximize signal quality while ensuring safety and usability in real-world healthcare settings. We are preparing to launch our first clinical trial in 2025—marking a major milestone in bringing this transformative solution to patients. At JiMED, we are not just creating devices—we are opening the frontier of neurotechnology.